Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New biopsy test could predict pancreatic cancer treatment success

NCT ID NCT07542041

First seen Apr 30, 2026 · Last updated Apr 30, 2026

Summary

This study is testing a new test called NEO-Match® that uses nanomechanical profiling to analyze biopsy samples from people with suspected pancreatic cancer. The goal is to see if the test can predict how well patients will respond to treatment and help doctors make better decisions. About 200 adults will provide an extra biopsy sample during their standard care and be followed for up to 2 years. No experimental treatments are given, and the test results are not used to guide care during the study.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PANCREATIC CANCER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Email: •••••@•••••

Locations

  • Moffitt Cancer Center

    RECRUITING

    Tampa, Florida, 33612, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact

Conditions

Explore the condition pages connected to this study.